ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NSCI Netscientific Plc

63.00
0.00 (0.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 63.00 61.00 65.00 63.00 63.00 63.00 1,000 07:30:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1M -3.09M -0.1312 -4.80 14.85M

NetScientific PLC HRS Expands Use of Wanda to All Patients (4607V)

03/11/2017 11:00am

UK Regulatory


Netscientific (LSE:NSCI)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Netscientific Charts.

TIDMNSCI

RNS Number : 4607V

NetScientific PLC

03 November 2017

NetScientific plc

("NetScientific" or the "Company" or the "Group")

Health Resource Solutions Expands Use of Wanda to All Patients

London, UK - November 3(rd) 2017 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that HRS Home Health (HRS) is expanding their use of Wanda to all of their home health patients. This follows a successful trial evaluation involving high-risk, co-morbid Congestive Heart Failure patients.

Commenting on the news, NetScientific's Chief Executive Officer and Chairman of Wanda, Francois R. Martelet said: "We are pleased to announce that HRS will be expanding its use of Wanda to all patients. We are also delighted to announce that HRS reported a 72% lower readmission rate for patients using Wanda, in addition to a high compliancy of 74%. We believe the data demonstrates Wanda's great technical capabilities, in addition to Wanda's ability to be integrated into clinician's workflow, both changing lives and reducing cost."

NetScientific holds a 61% stake on a fully diluted basis in Wanda.

For more information, please contact:

 
  NetScientific                            Tel: +44 (0)20 3514 1800 
   François R. Martelet, 
   M.D., CEO 
   Ian Postlethwaite, 
   CFO 
  Consilium Strategic 
   Communications                          Tel: +44 (0)20 3709 5700 
   Mary-Jane Elliott Jessica      netscientific@consilium-comms.com 
   Hodgson / 
   Chris Welsh / Laura 
   Thornton 
  Stifel Nicolaus Europe                  Tel: +44 (0) 20 7710 7600 
   Limited (NOMAD and Broker) 
   Jonathan Senior / David 
   Arch / Ben Maddison 
 

Health Resource Solutions (HRS Home Health) is using Wanda to increase patient compliance while decreasing readmissions

Summary: Health Resource Solutions is expanding their use of Wanda to all of their home health patients

After completing a successful program targeting high-risk, comorbid Congestive Heart Failure patients, Health Resource Solutions (HRS) is expanding their use of Wanda to HRS home health patients. HRS is using Wanda's machine learning and clinical analytics in unison with patient centered goals and HRS's transition of care guidelines that tie into clinical pathways to deliver better care for patients. The HRS Model concentrates on utilizing technology and services to provide the right care at the right time for the patient. HRS has increased patient compliance with individual care plans that include patient's goal. The integration of Wanda's technology with care interventions has decreased readmissions and costs of care. HRS is expanding this approach of integrating technology with interventions to its entire patient population to improve patient outcomes at lower costs.

HRS has found that HF patients that use Wanda have a 72% less probability of getting readmitted to the hospital. Furthermore, patients on Wanda showed an average compliancy of 74%, measured by daily interaction with the Wanda technology and adhering to their care plan.

Glenn Steigbigel, HRS CEO, noted: "We are very excited by the results we were able to achieve for our patients by reducing readmissions to 4.5% and high engagement and compliancy of those patient. Wanda has enabled us to deliver better care without increasing the workload for our clinicians, who are more effective with patients that are more engaged during the recovery process at home. Wanda is allowing us to identify variances during care delivery so that we can apply prevention and intervention techniques. By expanding Wanda, HRS continues to change lives by improving value for our patients and the clinicians that care for them. "

"Wanda is all about applying modern software applications powered by analytics, data science and deep healthcare knowledge in a meaningful, personal way that is unique to each patient and in the way nurses, doctors and the full care team can believe and then act on the information provided." Said Wanda CEO Foad Dabiri.

HRS is the largest privately owned high-tech nursing and rehabilitation home health agency in Chicago, IL. Since 2005, HRS has integrated data and technologies with home health services to measure and increase outcomes and value for patients, caregivers and clinicians. More information about HRS can be found at www.healthrs.net

Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning and modern software applications, enabling care providers to intelligently monitor, communicate with and manage their patients leading to improved outcomes and efficiencies. More information about Wanda can be found at www.yourwanda.com.

About NetScientific

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net

About Wanda

San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company. More information about Wanda can be found at www.yourwanda.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

STRDMMGMGZDGNZZ

(END) Dow Jones Newswires

November 03, 2017 07:00 ET (11:00 GMT)

1 Year Netscientific Chart

1 Year Netscientific Chart

1 Month Netscientific Chart

1 Month Netscientific Chart

Your Recent History

Delayed Upgrade Clock